Moloney Securities Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.44M | Sell |
36,169
-2,440
| -6% | -$224K | 0.41% | 59 |
|
|
2025
Q2 | $3.37M | Sell |
38,609
-5,401
| -12% | -$458K | 0.42% | 46 |
|
|
2025
Q1 | $3.95M | Buy |
44,010
+9,704
| +28% | +$868K | 0.53% | 36 |
|
|
2024
Q4 | $2.74M | Sell |
34,306
-78
| -0.2% | -$6.75K | 0.37% | 70 |
|
|
2024
Q3 | $3.1M | Buy |
34,384
+958
| +3% | +$80.6K | 0.42% | 63 |
|
|
2024
Q2 | $2.63M | Buy |
33,426
+1,871
| +6% | +$153K | 0.38% | 66 |
|
|
2024
Q1 | $2.75M | Buy |
31,555
+1,646
| +6% | +$140K | 0.41% | 65 |
|
|
2023
Q4 | $2.46M | Buy |
29,909
+1,680
| +6% | +$128K | 0.39% | 67 |
|
|
2023
Q3 | $2.21M | Buy |
28,229
+104
| +0.4% | +$8.71K | 0.4% | 64 |
|
|
2023
Q2 | $2.48M | Sell |
28,125
-255
| -0.9% | -$22K | 0.44% | 58 |
|
|
2023
Q1 | $2.29M | Buy |
28,380
+3,204
| +13% | +$261K | 0.43% | 60 |
|
|
2022
Q4 | $1.96M | Sell |
25,176
-1,817
| -7% | -$147K | 0.43% | 61 |
|
|
2022
Q3 | $2.18M | Sell |
26,993
-757
| -3% | -$68K | 0.53% | 51 |
|
|
2022
Q2 | $2.49M | Sell |
27,750
-623
| -2% | -$63.1K | 0.58% | 42 |
|
|
2022
Q1 | $3.15M | Buy |
28,373
+4,283
| +18% | +$452K | 0.61% | 40 |
|
|
2021
Q4 | $2.49M | Sell |
24,090
-1,469
| -6% | -$170K | 0.42% | 56 |
|
|
2021
Q3 | $3.2M | Buy |
25,559
+1,107
| +5% | +$143K | 0.58% | 48 |
|
|
2021
Q2 | $3.04M | Buy |
24,452
+2,958
| +14% | +$371K | 0.55% | 50 |
|
|
2021
Q1 | $2.54M | Sell |
21,494
-7,449
| -26% | -$873K | 0.5% | 62 |
|
|
2020
Q4 | $3.39M | Sell |
28,943
-64
| -0.2% | -$7.04K | 0.75% | 32 |
|
|
2020
Q3 | $3.01M | Buy |
29,007
+2,472
| +9% | +$248K | 0.8% | 33 |
|
|
2020
Q2 | $2.43M | Buy |
26,535
+1,801
| +7% | +$173K | 0.71% | 40 |
|
|
2020
Q1 | $2.23M | Buy |
24,734
+15,074
| +156% | +$1.6M | 0.8% | 37 |
|
|
2019
Q4 | $1.1M | Buy |
9,660
+448
| +5% | +$49.2K | 0.34% | 95 |
|
|
2019
Q3 | $1M | Buy |
9,212
+437
| +5% | +$45.6K | 0.33% | 94 |
|
|
2019
Q2 | $855K | Sell |
8,775
-139
| -2% | -$12.7K | 0.29% | 107 |
|
|
2019
Q1 | $812K | Buy |
8,914
+407
| +5% | +$36.4K | 0.28% | 114 |
|
|
2018
Q4 | $774K | Buy |
8,507
+746
| +10% | +$69.7K | 0.32% | 97 |
|
|
2018
Q3 | $763K | Sell |
7,761
-747
| -9% | -$69.1K | 0.26% | 108 |
|
|
2018
Q2 | $728K | Buy |
8,508
+382
| +5% | +$31.9K | 0.28% | 110 |
|
|
2018
Q1 | $652K | Sell |
8,126
-521
| -6% | -$43K | 0.26% | 119 |
|
|
2017
Q4 | $698K | Sell |
8,647
-9
| -0.1% | -$721 | 0.29% | 113 |
|
|
2017
Q3 | $673K | Buy |
8,656
+859
| +11% | +$71.3K | 0.3% | 100 |
|
|
2017
Q2 | $692K | Sell |
7,797
-31
| -0.4% | -$2.61K | 0.34% | 89 |
|
|
2017
Q1 | $631K | Buy |
7,828
+730
| +10% | +$57K | 0.33% | 96 |
|
|
2016
Q4 | $506K | Buy |
+7,098
| New | +$558K | 0.31% | 107 |
|
Other funds holding MDT
Moloney Securities Asset Management's MDT Position: Q3 2025 in Review
Moloney Securities Asset Management reduced its Medtronic (MDT) stake by 6.3% in Q3 2025, selling an estimated $224K and leaving 36,169 shares worth $3.44M. The position accounts for 0.41% of the portfolio, ranked #59.
Moloney Securities Asset Management first reported a position in MDT in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.95M in Q1 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Moloney Securities Asset Management held 36,169 shares of Medtronic worth $3.44M as of Q3 2025.
- Moloney Securities Asset Management sold 2,440 Medtronic shares in Q3 2025, an estimated $224K.
- Medtronic made up 0.41% of Moloney Securities Asset Management's portfolio in Q3 2025, its #59 holding.
- Moloney Securities Asset Management first reported a position in Medtronic in Q4 2016 and has held it in 36 quarters since.
- Moloney Securities Asset Management's Medtronic position peaked at $3.95M in Q1 2025.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.